GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...

Results showed that use of GLP-1 receptor agonists did not increase short-term medical or surgical complications among ...

GoodRx reports that GLP-1 medications will expand in use and accessibility, with new oral options and evolving insurance ...

Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...

Results show increased long-term risk for osteoporosis, gout and osteomalacia in one study; improved postoperative outcomes for common orthopaedic procedures in another NEW ORLEANS, March 2, 2026 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

By Hugo Francisco de Souza A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for ...

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) ...

GLP-1 RAs appear to be helping people reduce medication use and limit trips to the emergency department for chronic migraine ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple substances. Compared with the other medications, people taking the GLP-1 drugs ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...